12.42
Cellebrite Di Ltd Borsa (CLBT) Ultime notizie
Cellebrite DI strategy in focus, Nasdaq-listed shares under analyst scrutiny - AD HOC NEWS
Cellebrite DI (CLBT) Stock Could Be 23% Undervalued After Genesis AI Launch - simplywall.st
Cellebrite (CLBT)’s Total Addressable Market Is Large, Growing, And Likely Understated, According To DA Davidson - Yahoo Finance
Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now? - Insider Monkey
10 Stocks Under $20 That Will Explode - Insider Monkey
Cellebrite DI Ltd (CLBT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cellebrite DI Ltd (CLBT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cellebrite DI Ltd (CLBT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cellebrite DI Ltd (CLBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cellebrite DI Ltd (CLBT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Cellebrite DI Ltd (CLBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cellebrite DI Ltd (CLBT) Institutional Confidence - TradingKey
Cellebrite DI Ltd (CLBT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cellebrite DI Ltd (CLBT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Will Cellebrite’s AI‑Powered Genesis Platform Redefine Cellebrite DI's (CLBT) Narrative on Evidence Analysis? - simplywall.st
Cellebrite DI Ltd Faces Market Dynamics as Stock Volatility Surges - timothysykes.com
Cellebrite: Stronger Fundamentals Support A Buy Rating (NASDAQ:CLBT) - Seeking Alpha
Cellebrite Genesis: AI-Powered Investigative Solutions - SecurityInformed.com
Cellebrite Genesis: AI investigative tool launch - SourceSecurity.com
Cellebrite Launches the New Age of Investigations with Genesis, Now Generally Available - Macau Business
[PRNewswire] Cellebrite Launches the New Age of Investigations - Yonhap News Agency
Cellebrite DI Ltd. (CLBT) Latest Stock News & Headlines - Yahoo Finance
CLBT: AI-powered tools now deliver rapid, multi-source investigative insights, transforming case workflows - TradingView
Cellebrite launches AI investigation tool Genesis By Investing.com - Investing.com
Cellebrite Di Ltd. Announces General Availability of Genesis - marketscreener.com
Cellebrite DI Ltd stock (IL0011384071): Focus on digital intelligence growth after recent earnings - AD HOC NEWS
Cellebrite Announces Upcoming Investor Events on June 10, 2026 - PR Newswire
Cellebrite receives FedRAMP High Authorization for cloud platform - Investing.com
[PRNewswire] Cellebrite Announces Upcoming Investor Events - Yonhap News Agency
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market - The Motley Fool
TD Cowen reiterates Buy rating on Cellebrite stock at $23 target By Investing.com - Investing.com South Africa
TD Cowen reiterates Buy rating on Cellebrite stock at $23 target - Investing.com Australia
Tracking How the Cellebrite (CLBT) Investment Narrative Is Evolving Without New Analyst Targets - Yahoo Finance
CLBT News | CELLEBRITE DI LTD (NASDAQ:CLBT) - ChartMill
Cellebrite DI Ltd. Hits Day High with 11.59% Surge in Stock Price - MarketsMojo
Cellebrite DI Ltd. Hits Day High with 7.74% Surge in Stock Price - Markets Mojo
Cellebrite DI (CLBT) Is Up 20.4% After FedRAMP Win And AI Launch MomentumHas The Bull Case Changed? - simplywall.st
126,264-share resale planned for CLBT (NASDAQ: CLBT) via Morgan Stanley - Stock Titan
Why is Cellebrite DI stock rallying 6% today? By Investing.com - Investing.com South Africa
Is It Time To Reassess Cellebrite DI (CLBT) After The Recent Share Price Rebound? - simplywall.st
Why is Cellebrite stock surging 8% today? By Investing.com - Investing.com Australia
CLBT: Upcoming Virtual Meeting Announced for June 4 - GuruFocus
A Look At Cellebrite DI (NasdaqGS:CLBT) Valuation As AI And FedRAMP Cloud Momentum Build - simplywall.st
Cellebrite DI Ltd. (CLBTW) Stock Price, News, Quote & History - Yahoo Finance
Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows - MarketBeat
TD Cowen Maintains Cellebrite(CLBT.US) With Buy Rating, Maintains Target Price $23 - Moomoo
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):